Solution-phase synthesis of a library of 3,5,7-trisubstituted 3H-[1,2,3]triazolo[4,5-d]pyrimidines

Journal of Combinatorial Chemistry

Volumn 5, Issue 5, 2003, Pages 653-659

  Baindur, Nand ^a   Chadha, Naresh ^a   Player, Mark R ^a  

^a JOHNSON AND JOHNSON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4,6 DICHLORO 2 METHYL 5 NITROPYRIMIDINE; 4,6 DICHLORO 5 NITROPYRIMIDINE; 4,6 DIHYDROXY 2 METHYL 5 NITROPYRIMIDINE; 4,6 DIHYDROXY 2 METHYLPYRIMIDINE; 4,6 DIHYDROXY 5 NITROPYRIMIDINE; 4,6 DIHYDROXYPYRIMIDINE; AMINE; HYDRAZINE; HYDROXYLAMINE; PYRIMIDINE DERIVATIVE; UNCLASSIFIED DRUG;

AQUEOUS SOLUTION; ARTICLE; CYCLIZATION; DRUG SYNTHESIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; THIN LAYER CHROMATOGRAPHY;

EID: 0141460549     PISSN: 15204766     EISSN: None     Source Type: Journal    
DOI: 10.1021/cc020110x     Document Type: Article

References (36)

1. (a) Dolle, R. E. J. Comb. Chem. 2001, 3, 477-517.
2. (b) Franzen, R. G. J. Comb. Chem. 2002, 2, 195-214.
3. (c) Houghten, R. A.; Pinilla, C.; Appel, J. R.; Blondelle, S. E.; Dooley, C. T.; Eichler, J.; Nefzi, A.; Ostresh, J. M. J. Med. Chem. 1999, 42, 3743-3778.
4. (d) Nefzi, A.; Ostresh, J. M.; Houghten, R. A. Chem. Rev. 1997, 97, 449-472.
5. (e) Thompson, L. A.; Ellman, J. A. Chem. Rev. 1996, 96, 555-600.
6. (f) Gordon, E. M.; Barret, R. W.; Dower, W. J.; Fodor, S. P. A.; Gallop, M. A. J. Med. Chem. 1994, 37, 1385-1401.
7. (a) Ley, S. V. Multistep Organic Synthesis Using Solid-supported Reagents and J. Chem. Soc., Perkin Trans. 1 2000, 3815-4195.
8. (b) Thompson, L. A. Curr. Opin. Chem. Biol. 2000, 4, 324-337.
9. (c) Kirschning, A.; Monenschein, H.; Wittenberg, R. Angew. Chem., Int. Ed., Engl. 2001, 40, 650-679.
10. (d) Ley, S. V. II Farmaco. 2002, 57, 231-330.
11. (e) Drewry, D. H.; Coe, D. M.; Poon, S. Med. Res. Rev. 1999, 19, 97-148.
12. (f) Flynn, D. L. Med. Chem. Res. 1998, 8, 219-243.
13. (g) Flynn, D. L.; Devraj, R. V.; Parlow, J. J. Curr. Opin. Drug. Discov. Dev. 1998, 1, 41-50.
14. (h) Booth, R. J., Hodges, J. C. Acc. Chem. Res. 1999, 32, 18-26.
15. (i) Parlow, J. J.; Devraj, R. V.; South, M. S. Curr. Opin. Drug. Discov. Dev. 1999, 3, 320-336.
16. (a) Vesely, J.; Havlicek, L.; Strnad, M.; Blow, J. J.; Donella-Deana, A. ; Pinna, L.; Letham, D. S.; Kato, J. Y.; Detivaud, L.; Leclerc, S.; Meijer, L. Eur. J. Biochem. 1994, 224, 771-786.
17. (b) Havlicek, L.; Hanus, J.; Vesely, J.; Leclerc, S.; Meijer, L.; Shaw, G.; Strnad, M. J. Med. Chem. 1997, 40, 408-412.
18. (c) Meijer, L.; Borgne, A.; Mulner, O.; Chong, J. P. J.; Blow, J. J.; Inagaki, N.; Inagaki, M.; Delcros, J.-G.; Moulinoux, J. P. Eur. J. Biochem. 1997, 243, 527-536.
19. (d) Norman, T. C.; Gray, N. S.; Koh, J. T.; Schultz, P. G. J. Am. Chem. Soc. 1996, 118, 7430-7431.
20. (e) Gray, N. S.; Wodicka, L.; Thunnissen, A. M. W. H.; Norman, T. C.; Kwon, S.; Espinoz, F. H.; Morgan, D. O.; Barnes, G.; Leclerc, S.; Meijer, L.; Kim, S. H.; Lockhart, D. J.; Schultz, P. G. Science, 1998, 281, 533-538.
21. (f) Schow, S. R.; Mackman, R. L.; Blum, C. L.; Brooks, E.; Harshma, A. G.; Joly, A.; Kerwar, S. S.; Lee, G.; Shiffman, D.; Nelson, M. G.; Wang, X.; Wick, M. M.; Zhang, X.; Lum, R. T. Bioorg. Med. Chem. Lett. 1997, 7, 2697-2702.
22. (g) Imbach, P.; Capraro, H. G.; Furet, P.; Mett, H.; Meyer, T.; Zimmermann, J. Bioorg. Med. Chem. Lett. 1999, 9, 91-96.
23. (h) Perez, O. D.; Chang, Y.-T.; Rosania, G.; Sutherlin, D.; Schultz, P. G. Chem. Biol. 2002, 9, 475-483.
24. (i) Chang, Y.-T.; Wignall, S. M.; Rosania, G. R.; Gray, N. S.; Hanson, S. R.; Su, A.; Merlie, J.; Moon, H.; Sangankar, S. B.; Perez, O.; Heald, R.; Schultz, P. G. J. Med. Chem. 2001, 44, 4497-4500.
25. (a) Albert, A. Adv. Heterocycl. Chem. 1986, 39, 117-180.
26. (a) Betti, L.; Biagi, G.; Giannaccini, G.; Giorgi, I.; Livi, O.; Lucacchini, A.; Manera, C.; Scartoni, V. Eur. J. Med. Chem. 1999, 34, 867-875.
27. (b) Betti, L.; Biagi, G.; Giannaccini, G.; Giorgi, I.; Livi, O.; Lucacchini, A.; Manera, C.; Scartoni, V. J. Med. Chem. 1998, 41, 668-673.
28. (c) Biagi, G.; Franchi, M.; Giorgi, I.; Livi, O.; Scartoni, V. J. Heterocycl. Chem. 1989, 26, 39-43.
29. (d) Barili, P. L.; Biagi, G.; Mucci, L.; Scartoni, V. J. Heterocycl. Chem. 1987, 24, 997-1001.
30. (e) Barili, P. L.; Biagi, G.; Livi, O.; Scartoni, V. J. Heterocycl. Chem. 1985, 22, 1607-1609.
31. (f) Higashino, T.; Katori, T.; Kawaraya, H.; Hayashi, E. Chem. Pharm. Bull. 1980, 28, 337-343.
32. (a) Guile, S.; Martin, B. Preparation and Use of 1,2,3-Triazolo[4, 5d]pyrimidines as P2T Receptor Ligands. PCT Int. Appl. WO 0238571 A1 20020516; 2002.
33. (b) Brown, R.; Guile, S.; Pairaudeau, G.; Springthorpe, B. Preparation and Use of 1,2,3-Triazolo[4, 5d]pyrimidines as P2T Receptor Ligands. PCT Int. Appl. WO 0238570, A1 20020516; 2002.
34. (c) Preparation of 7-Amino-3-benzyl-3H-1,2,3-triazolo[4,5d]-pyrimidines as anti-convulsants. Eur. Pat. Appl. EP 288431, A1 19881026; 1988.
35. (a) Kenner, G. W.; Lythgoe, B.; Todd, A. R.; Topham, A. J. Chem. Soc. 1943, 388-390.
36. (b) Hanan, G. S.; Schubert, U. S.; Volkmer, D.; Riviere, E.; Lehn, J.-M. Can. J. Chem. 1997, 75, 169-182.